On the public citation graph

Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment

https://doi.org/10.4155/tde.10.13

0 signed · 627 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.200800491openalex-snapshot

Paclitaxel‐Initiated, Controlled Polymerization of Lactide for the Formulation of Polymeric Nanoparticulate Delivery Vehicles

inferredcites →https://doi.org/10.1002/cmdc.200700121openalex-snapshot

Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates

inferredcites →https://doi.org/10.1002/jps.2600840420openalex-snapshot

Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System

inferredcites →https://doi.org/10.1002/smll.200900621openalex-snapshot

Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer Cells

inferredcites →https://doi.org/10.1007/3540587888_14openalex-snapshot

Polymer conjugates with anticancer activity

inferredcites →https://doi.org/10.1007/bf00686150openalex-snapshot

Effects of verapamil on the pharmacokinetics and metabolism of epirubicin

inferredcites →https://doi.org/10.1007/bf00874439openalex-snapshot

Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome)

inferredcites →https://doi.org/10.1007/pl00006740openalex-snapshot

Interaction between gemcitabine and mitomycin-C in vitro

inferredcites →https://doi.org/10.1007/s11095-006-0284-8openalex-snapshot

Nanotechnology: Intelligent Design to Treat Complex Disease

inferredcites →https://doi.org/10.1016/0005-2736(71)90184-2openalex-snapshot

Single bilayer liposomes

inferredcites →https://doi.org/10.1016/0005-2736(79)90085-3openalex-snapshot

Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes

inferredcites →https://doi.org/10.1016/1040-8428(94)00131-copenalex-snapshot

Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs

inferredcites →https://doi.org/10.1016/j.addr.2004.02.014openalex-snapshot

Nanoparticle and targeted systems for cancer therapy

inferredcites →https://doi.org/10.1016/j.addr.2009.05.006openalex-snapshot

Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

inferredcites →https://doi.org/10.1016/j.biomaterials.2009.02.040openalex-snapshot

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers

inferredcites →https://doi.org/10.1016/j.biomaterials.2009.06.026openalex-snapshot

Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier

inferredcites →https://doi.org/10.1016/j.biomaterials.2009.11.077openalex-snapshot

Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA–PCL–PDMAEMA triblock copolymers

inferredcites →https://doi.org/10.1016/j.bmc.2007.11.052openalex-snapshot

Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis

inferredcites →https://doi.org/10.1016/j.bone.2005.12.049openalex-snapshot

Sequence-dependent synergistic effects of ibandronate in combination with antiestrogens on growth inhibition of estrogen receptor-positive breast cancer cells

inferredcites →https://doi.org/10.1016/j.ejps.2009.02.018openalex-snapshot

Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles

inferredcites →https://doi.org/10.1016/j.jconrel.2007.05.038openalex-snapshot

Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents

inferredcites →https://doi.org/10.1016/j.leukres.2008.06.028openalex-snapshot

In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy

inferredcites →https://doi.org/10.1016/s0022-2836(65)80093-6openalex-snapshot

Diffusion of univalent ions across the lamellae of swollen phospholipids

inferredcites →https://doi.org/10.1016/s0142-9612(99)00125-8openalex-snapshot

Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles

inferredcites →https://doi.org/10.1016/s0168-3659(01)00315-7openalex-snapshot

Tumor targeting using anti-her2 immunoliposomes

inferredcites →https://doi.org/10.1016/s0959-8049(01)00050-8openalex-snapshot

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

inferredcites →https://doi.org/10.1021/ja073231fopenalex-snapshot

Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug Design

inferredcites →https://doi.org/10.1021/ja075181kopenalex-snapshot

Paclitaxel-Functionalized Gold Nanoparticles

inferredcites →https://doi.org/10.1021/ja804947uopenalex-snapshot

Targeted Paclitaxel by Conjugation to Iron Oxide and Gold Nanoparticles

inferredcites →https://doi.org/10.1021/ja805570fopenalex-snapshot

Functionalized Single-Walled Carbon Nanotubes as Rationally Designed Vehicles for Tumor-Targeted Drug Delivery

inferredcites →https://doi.org/10.1021/ja8084675openalex-snapshot

Ring-Opening Polymerization-Mediated Controlled Formulation of Polylactide−Drug Nanoparticles

inferredcites →https://doi.org/10.1021/mp800240jopenalex-snapshot

Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells

inferredcites →https://doi.org/10.1021/nn9014032openalex-snapshot

Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery

inferredcites →https://doi.org/10.1023/a:1015752331041openalex-snapshot

An Open Label Trial of Sustained-release Cytarabine (DepoCyt™) for the Intrathecal Treatment of Solid Tumor Neoplastic Meningitis

inferredcites →https://doi.org/10.1023/a:1020604623427openalex-snapshot

Maladaptive Growth in the Failing Heart: The Cardiomyopathy of Overload

inferredcites →https://doi.org/10.1023/a:1024431218327openalex-snapshot

Synergy Between 3′Azido-3′deoxythymidine and Paclitaxel in Human Pharynx FaDu Cells

inferredcites →https://doi.org/10.1038/nature03794openalex-snapshot

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

inferredcites →https://doi.org/10.1038/nbt.1549openalex-snapshot

Synergistic drug combinations tend to improve therapeutically relevant selectivity

inferredcites →https://doi.org/10.1038/nmat1737openalex-snapshot

Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer

inferredcites →https://doi.org/10.1038/nnano.2007.387openalex-snapshot

Nanocarriers as an emerging platform for cancer therapy

inferredcites →https://doi.org/10.1038/nrd2614openalex-snapshot

Nanoparticle therapeutics: an emerging treatment modality for cancer

inferredcites →https://doi.org/10.1038/sj.bjc.6692027openalex-snapshot

Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants

inferredcites →https://doi.org/10.1038/sj.clpt.6100400openalex-snapshot

Nanoparticles in Medicine: Therapeutic Applications and Developments

inferredcites →https://doi.org/10.1039/b914071aopenalex-snapshot

Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers

inferredcites →https://doi.org/10.1073/pnas.0601755103openalex-snapshot

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

inferredcites →https://doi.org/10.1080/02652040802312572openalex-snapshot

Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics

inferredcites →https://doi.org/10.1080/08982100500364081openalex-snapshot

6-Mercaptopurine and Daunorubicin Double Drug Liposomes—Preparation, Drug-Drug Interaction and Characterization

inferredcites →https://doi.org/10.1080/10611860802473154openalex-snapshot

Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy

inferredcites →https://doi.org/10.1093/jnci/83.2.105openalex-snapshot

Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy Administration

inferredcites →https://doi.org/10.1093/protein/gzh040openalex-snapshot

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting

inferredcites →https://doi.org/10.1093/protein/gzn055openalex-snapshot

Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors

inferredcites →https://doi.org/10.1097/00001813-200002000-00009openalex-snapshot

Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer

inferredcites →https://doi.org/10.1097/cad.0b013e328336e940openalex-snapshot

Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment

inferredcites →https://doi.org/10.1109/iembs.2009.5334938openalex-snapshot

Controlled formulation of doxorubicin-polylactide nanoconjugates for cancer drug delivery

inferredcites →https://doi.org/10.1111/j.2042-7158.1995.tb05815.xopenalex-snapshot

PEG-coated Poly(lactic acid) Nanoparticles for the Delivery of Hexadecafluoro Zinc Phthalocyanine to EMT-6 Mouse Mammary Tumours

inferredcites →https://doi.org/10.1124/jpet.107.121632openalex-snapshot

Tumor Priming Enhances Delivery and Efficacy of Nanomedicines

inferredcites →https://doi.org/10.1124/jpet.108.140095openalex-snapshot

Tumor-Penetrating Microparticles for Intraperitoneal Therapy of Ovarian Cancer

inferredcites →https://doi.org/10.1126/science.279.5349.377openalex-snapshot

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

inferredcites →https://doi.org/10.1146/annurev.med.53.082901.103929openalex-snapshot

Mechanisms of Cancer Drug Resistance

inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0515openalex-snapshot

Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors

inferredcites →https://doi.org/10.1158/1535-7163.mct-06-0118openalex-snapshot

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

inferredcites →https://doi.org/10.1158/1535-7163.mct-09-0243openalex-snapshot

Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo

inferredcites →https://doi.org/10.1200/jco.1998.16.7.2445openalex-snapshot

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

inferredcites →https://doi.org/10.1200/jco.2005.08.002openalex-snapshot

Nanoparticle Albumin–Bound Paclitaxel for Metastatic Breast Cancer

inferredcites →https://doi.org/10.1615/critrevtherdrugcarriersyst.v16.i3.10openalex-snapshot

Drug-Polymer Conjugates Containing Acid-Cleavable Bonds

inferredcites →https://doi.org/10.2165/00126839-200405020-00012openalex-snapshot

Vincristine Liposomal - INEX

inferredcites →https://doi.org/10.2174/092986710790416290openalex-snapshot

Development of Nanoparticles for Antimicrobial Drug Delivery

inferredcites →https://doi.org/10.2174/138920009790274540openalex-snapshot

Therapeutic Nanoparticles to Combat Cancer Drug Resistance

inferredcites →https://doi.org/10.2217/17435889.3.6.761openalex-snapshot

Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer

inferredcites →https://doi.org/10.3109/07357909309020256openalex-snapshot

The Effect of Anticancer Drug Sequence in Experimental Combination Chemotherapy

inferredcites →https://doi.org/10.3727/000000006783980937openalex-snapshot

Increased Preclinical Efficacy of Irinotecan and Floxuridine Coencapsulated Inside Liposomes Is Associated With Tumor Delivery of Synergistic Drug Ratios

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4500358openalex-extracted

Dual Controlled Delivery of Furosemide and Atenolol Using the Biodegradable Nano System for Antihypertensive Therapy

inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm070openalex-snapshot

Cancer Nanotechnology

inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm070.pub2openalex-snapshot

Cancer Nanotechnology

inferred← citeshttps://doi.org/10.1002/9781394175222.ch9openalex-snapshot

Properties and Applications of Dendrimers

inferred← citeshttps://doi.org/10.1002/adfm.201303222openalex-snapshot

Gel–Liposome‐Mediated Co‐Delivery of Anticancer Membrane‐Associated Proteins and Small‐Molecule Drugs for Enhanced Therapeutic Efficacy

inferred← citeshttps://doi.org/10.1002/adfm.201705451openalex-snapshot

Porphyrinic Metal–Organic Frameworks Coated Gold Nanorods as a Versatile Nanoplatform for Combined Photodynamic/Photothermal/Chemotherapy of Tumor

inferred← citeshttps://doi.org/10.1002/adfm.201806818openalex-snapshot

Conjugated Polymer Nanoparticles for Imaging, Cell Activity Regulation, and Therapy

inferred← citeshttps://doi.org/10.1002/adhm.201200338openalex-snapshot

Optically Traceable Solid Lipid Nanoparticles Loaded with siRNA and Paclitaxel for Synergistic Chemotherapy with In situ Imaging

inferred← citeshttps://doi.org/10.1002/adma.201602763openalex-snapshot

Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy

inferred← citeshttps://doi.org/10.1002/adma.202000091openalex-snapshot

Multicompartment Tubular Micromotors Toward Enhanced Localized Active Delivery

inferred← citeshttps://doi.org/10.1002/adma.202110490openalex-snapshot

Co‐Delivery of Precisely Prescribed Multi‐Prodrug Combination by an Engineered Nanocarrier enables Efficient Individualized Cancer Chemotherapy

inferred← citeshttps://doi.org/10.1002/admi.202001055openalex-snapshot

Injectable Biomaterials for Treatment of Glioblastoma

inferred← citeshttps://doi.org/10.1002/adtp.201800100openalex-snapshot

Metal‐Organic Framework Mediated Multifunctional Nanoplatforms for Cancer Therapy

inferred← citeshttps://doi.org/10.1002/adtp.201900165openalex-snapshot

Thermosensitive Polypeptide Hydrogels Co‐Loaded with Two Anti‐Tumor Agents to Reduce Multi‐Drug Resistance and Enhance Local Tumor Treatment

inferred← citeshttps://doi.org/10.1002/advs.202003584openalex-snapshot

Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer

inferred← citeshttps://doi.org/10.1002/ange.201903807openalex-snapshot

Molecular Engineering‐Based Aptamer–Drug Conjugates with Accurate Tunability of Drug Ratios for Drug Combination Targeted Cancer Therapy

inferred← citeshttps://doi.org/10.1002/anie.201903807openalex-snapshot

Molecular Engineering‐Based Aptamer–Drug Conjugates with Accurate Tunability of Drug Ratios for Drug Combination Targeted Cancer Therapy

inferred← citeshttps://doi.org/10.1002/bit.26566openalex-snapshot

Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature

inferred← citeshttps://doi.org/10.1002/cbf.3668openalex-snapshot

Sulindac and vitamin D3 synergically inhibit proliferation of MCF ‐7 breast cancer cell through AMPK /Akt/β‐catenin axis in vitro

inferred← citeshttps://doi.org/10.1002/ejoc.201403088openalex-snapshot

Synthesis and Cytotoxic Activity of Self‐Assembling Squalene Conjugates of 3‐[(Pyrrol‐2‐yl)methylidene]‐2,3‐dihydro‐1H‐indol‐2‐one Anticancer Agents

inferred← citeshttps://doi.org/10.1002/jbm.a.35591openalex-snapshot

Salinomycin encapsulated nanoparticles as a targeting vehicle for glioblastoma cells

inferred← citeshttps://doi.org/10.1002/jcp.28192openalex-snapshot

Fabrication of novel combinatorial drug encapsulated micelles for enhanced tumor targeting in intestinal cancer in mouse model

inferred← citeshttps://doi.org/10.1002/jcp.28599openalex-snapshot

Combinatorial effects of radiofrequency hyperthermia and radiotherapy in the presence of magneto‐plasmonic nanoparticles on MCF‐7 breast cancer cells

inferred← citeshttps://doi.org/10.1002/lsm.22955openalex-snapshot

Assessing fluorescence detection and effective photothermal therapy of near‐infrared polymer nanoparticles using alginate tissue phantoms

inferred← citeshttps://doi.org/10.1002/mabi.201400035openalex-snapshot

Overcoming Cancer Multidrug Resistance by Codelivery of Doxorubicin and Verapamil with Hydrogel Nanoparticles

inferred← citeshttps://doi.org/10.1002/pat.6461openalex-snapshot

Polymeric nanotheranostics for solid tumor management: Recent developments and global regulatory landscape

inferred← citeshttps://doi.org/10.1002/ppsc.201400115openalex-snapshot

A Functionalized Hollow Mesoporous Silica Nanoparticles-Based Controlled Dual-Drug Delivery System for Improved Tumor Cell Cytotoxicity

inferred← citeshttps://doi.org/10.1002/slct.202201288openalex-snapshot

Potential of Dual Drug Delivery Systems: MOF as Hybrid Nanocarrier for Dual Drug Delivery in Cancer Treatment

inferred← citeshttps://doi.org/10.1002/smll.201303740openalex-snapshot

Microfluidic Assembly of Monodisperse Multistage pH‐Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi‐Drug Delivery

inferred← citeshttps://doi.org/10.1002/smll.202004975openalex-snapshot

Nanomedicines for Endometriosis: Lessons Learned from Cancer Research

inferred← citeshttps://doi.org/10.1002/wnan.1282openalex-snapshot

Nanoparticle approaches against bacterial infections

inferred← citeshttps://doi.org/10.1002/wnan.1353openalex-snapshot

Combinatorial nanomedicines for colon cancer therapy

inferred← citeshttps://doi.org/10.1002/wnan.1976openalex-snapshot

Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy

inferred← citeshttps://doi.org/10.1007/978-3-030-13296-5_14openalex-snapshot

Engineered Nanoparticle-Based Approaches to the Protection of Plants Against Pathogenic Microorganisms

inferred← citeshttps://doi.org/10.1007/978-3-030-21583-5_12openalex-snapshot

Recent Advances in Nanodentistry

inferred← citeshttps://doi.org/10.1007/978-3-030-41464-1_12openalex-snapshot

Implications of Nanotechnology in Cancer Diagnostics and Therapeutics

inferred← citeshttps://doi.org/10.1007/978-3-030-76235-3_5openalex-snapshot

Controlled Delivery and Reduced Side Effects of Anticancer Drugs Complexed with Polymeric Nanocarrier

inferred← citeshttps://doi.org/10.1007/978-3-031-14848-4_7openalex-snapshot

Polymeric Nanoparticles that Entrap Drug Combinations Targeted to Solid Tumors

inferred← citeshttps://doi.org/10.1007/978-3-031-27156-4_2openalex-snapshot

Transforming Diagnosis and Therapeutics Using Cancer Genomics

inferred← citeshttps://doi.org/10.1007/978-3-031-61877-2_5openalex-snapshot

Kontrollierte Abgabe und reduzierte Nebenwirkungen von Krebsmedikamenten, die mit polymerem Nanoträger komplexiert sind

inferred← citeshttps://doi.org/10.1007/978-3-031-69044-0_1-1openalex-snapshot

Introduction to Nanotechnology in Medicine

inferred← citeshttps://doi.org/10.1007/978-3-319-21813-7_3openalex-snapshot

Dendritic Nanomaterials for Therapeutic and Diagnostic Applications

inferred← citeshttps://doi.org/10.1007/978-3-319-56979-6_10openalex-snapshot

Characteristics and Applications of Silver Nanoparticles

inferred← citeshttps://doi.org/10.1007/978-3-319-74814-6_7openalex-snapshot

Platinum in Biomedical Applications

inferred← citeshttps://doi.org/10.1007/978-81-322-2511-9_9openalex-snapshot

Recent Advances in Chitosan-Based Nanomedicines for Cancer Chemotherapy

inferred← citeshttps://doi.org/10.1007/978-94-017-8739-0_9openalex-snapshot

Design, Synthesis, and Functionalization of Nanomaterials for Therapeutic Drug Delivery

inferred← citeshttps://doi.org/10.1007/978-981-10-8064-7_7openalex-snapshot

Plant Metabolites as New Leads to Anticancer Drug Discovery: Approaches and Challenges

inferred← citeshttps://doi.org/10.1007/978-981-15-1293-3_4openalex-snapshot

Interaction of Nanomaterials with Biological Systems

inferred← citeshttps://doi.org/10.1007/978-981-16-9190-4_3openalex-snapshot

Understanding the Pharmacology and Pharmacotherapeutics for Infectious Diseases

inferred← citeshttps://doi.org/10.1007/978-981-33-4497-6_1openalex-snapshot

Fundamentals of Nanocarriers and Drug Targeting

inferred← citeshttps://doi.org/10.1007/978-981-97-3545-7_14openalex-snapshot

Translational Aspect of Cancer Nanomedicine: Present Status and Future Perspectives

inferred← citeshttps://doi.org/10.1007/978-981-99-3746-2_31openalex-snapshot

Recent Advances of Iron Oxide Nanoparticles-Based Nanomedicine for Prostate Cancer (Review)

inferred← citeshttps://doi.org/10.1007/s00210-023-02907-6openalex-snapshot

A novel nanoformulation of parthenolide coated with polydopamine shows selective cytotoxicity and induces apoptosis in gastric cancer cells

inferred← citeshttps://doi.org/10.1007/s10311-019-00897-7openalex-snapshot

Nanocarrier-mediated co-delivery systems for lung cancer therapy: recent developments and prospects

inferred← citeshttps://doi.org/10.1007/s10439-026-04124-7openalex-snapshot

Cubosome-Based Nanocarriers in Cancer Therapy: Design Optimization, Analytical Characterization, and Translational Perspectives

inferred← citeshttps://doi.org/10.1007/s10924-023-02865-3openalex-snapshot

Preparation and Characterization of the Myricetin-Loaded Mesoporous Silica Nanoparticle Surface Decorated with Polydopamine and Evaluation of Its Anti-cancer and Anti-oxidant Activities In Vitro

inferred← citeshttps://doi.org/10.1007/s11051-014-2527-7openalex-snapshot

Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point

inferred← citeshttps://doi.org/10.1007/s11095-017-2337-6openalex-snapshot

Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer

inferred← citeshttps://doi.org/10.1007/s11095-018-2370-0openalex-snapshot

A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis

inferred← citeshttps://doi.org/10.1007/s11426-020-9964-xopenalex-snapshot

Dual drug delivery system with flexible and controllable drug ratios for synergistic chemotherapy

inferred← citeshttps://doi.org/10.1007/s11705-016-1574-2openalex-snapshot

Curcumin based combination therapy for anti-breast cancer: from in vitro drug screening to in vivo efficacy evaluation

inferred← citeshttps://doi.org/10.1007/s12195-017-0490-yopenalex-snapshot

Phenotypically Screened Carbon Nanoparticles for Enhanced Combinatorial Therapy in Triple Negative Breast Cancer

inferred← citeshttps://doi.org/10.1007/s12247-022-09688-0openalex-snapshot

Design, Development, In Silico, and In Vitro Characterization of Camptothecin-Loaded Mixed Micelles: In Vitro Testing of Verapamil and Ranolazine for Repurposing as Coadjuvant Therapy in Cancer

inferred← citeshttps://doi.org/10.1007/s12247-025-09971-wopenalex-snapshot

Conjugate Delivery of D-Cycloserine and Moxifloxacin via Hydrolysable Cross Linkers -Mesoporous Silica Nanoparticles for Synergistic Effect on Multiple Drug Resistant on Tuberculosis

inferred← citeshttps://doi.org/10.1007/s12274-015-0760-8openalex-snapshot

Anti-migratory and increased cytotoxic effects of novel dual drug-loaded complex hybrid micelles in triple negative breast cancer cells

inferred← citeshttps://doi.org/10.1007/s12668-024-01515-9openalex-snapshot

Gelatin/ CMC /HAP Nanocomposites Based on Double Micro-emulsion for Delivery of 5-FU: Synthesis and Chemical–Physical Characterization

inferred← citeshttps://doi.org/10.1007/s12668-026-02436-5openalex-snapshot

Bioinspired Sericin-PCL Nanoparticles for Sustained Delivery in Cancer with Antioxidant and Antibacterial Efficacies

inferred← citeshttps://doi.org/10.1007/s13205-020-02391-2openalex-snapshot

Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation

inferred← citeshttps://doi.org/10.1007/s13346-021-01041-1openalex-snapshot

Co-delivery systems: hope for clinical application?

inferred← citeshttps://doi.org/10.1007/s13346-022-01256-wopenalex-snapshot

Multifunctional nanomedicine strategies to manage brain diseases

inferred← citeshttps://doi.org/10.1007/s40005-014-0152-1openalex-snapshot

Preparation and characterization of alginate gel core-lipid nanocapsules for co-delivery of hydrophilic and hydrophobic anti-cancer drugs

inferred← citeshttps://doi.org/10.1007/s40199-019-00267-2openalex-snapshot

Delivery of natural phenolic compounds for the potential treatment of lung cancer

inferred← citeshttps://doi.org/10.1007/s40199-019-00308-wopenalex-snapshot

Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy

inferred← citeshttps://doi.org/10.1007/s40199-025-00569-8openalex-snapshot

Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer

inferred← citeshttps://doi.org/10.1007/s40242-022-2116-8openalex-snapshot

A DNA Nano-train Carrying a Predefined Drug Combination for Cancer Therapy

inferred← citeshttps://doi.org/10.1007/s40820-020-00482-6openalex-snapshot

A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy

inferred← citeshttps://doi.org/10.1007/s42250-025-01435-5openalex-snapshot

Review on Synthesis and Characterization of TiO2 Nanoparticles: A Potent Antimicrobial and Drug Delivery Agent

inferred← citeshttps://doi.org/10.1007/s44174-026-00702-4openalex-snapshot

Controlled Co-release of D-Cycloserine and Moxifloxacin from Mesoporous Nanoparticles for Synergistic MDR-TB Treatment

inferred← citeshttps://doi.org/10.1016/b978-0-08-100716-7.00003-9openalex-snapshot

Self-assembled nanomaterials

inferred← citeshttps://doi.org/10.1016/b978-0-08-100716-7.00017-9openalex-snapshot

Polymeric and liposomal nanomaterials

inferred← citeshttps://doi.org/10.1016/b978-0-08-100963-5.00009-4openalex-snapshot

Nanotherapeutics in the management of infections and cancer

inferred← citeshttps://doi.org/10.1016/b978-0-08-101750-0.00012-xopenalex-snapshot

Drug delivery systems based on nonimmunogenic biopolymers

inferred← citeshttps://doi.org/10.1016/b978-0-08-102548-2.00004-4openalex-snapshot

Nano- and microparticles as drug carriers

inferred← citeshttps://doi.org/10.1016/b978-0-12-801024-2.00003-0openalex-snapshot

Drug Delivery Vehicles

inferred← citeshttps://doi.org/10.1016/b978-0-12-813679-9.00005-1openalex-snapshot

Breast Cancer–Targeted Therapy Using Nanocarriers

inferred← citeshttps://doi.org/10.1016/b978-0-12-813687-4.00009-8openalex-snapshot

Developing liposomal nanomedicines for treatment of patients with neuroblastoma

inferred← citeshttps://doi.org/10.1016/b978-0-12-813691-1.00001-4openalex-snapshot

Exploring the binding potential of carbon nanotubes and fullerene towards major drug targets of multidrug resistant bacterial pathogens and their utility as novel therapeutic agents

inferred← citeshttps://doi.org/10.1016/b978-0-12-814029-1.00008-9openalex-snapshot

Combination Strategies for Targeted Delivery of Nanoparticles for Cancer Therapy

inferred← citeshttps://doi.org/10.1016/b978-0-12-814029-1.00010-7openalex-snapshot

Nanoparticles as Delivery Systems in Cancer Therapy

inferred← citeshttps://doi.org/10.1016/b978-0-12-814835-8.00009-1openalex-snapshot

Innovation in nanomedicine and engineered nanomaterials for therapeutic purposes

inferred← citeshttps://doi.org/10.1016/b978-0-12-816505-8.00008-4openalex-snapshot

Novel multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer

inferred← citeshttps://doi.org/10.1016/b978-0-12-817909-3.00017-0openalex-snapshot

Nanocarriers in Different Preclinical and Clinical Stages

inferred← citeshttps://doi.org/10.1016/b978-0-12-818627-5.00013-0openalex-snapshot

Applications of liposomes in nanomedicine

inferred← citeshttps://doi.org/10.1016/b978-0-12-819777-6.00015-9openalex-snapshot

Combinational delivery therapies of nucleic acids for cancer treatment

inferred← citeshttps://doi.org/10.1016/b978-0-12-819793-6.00012-6openalex-snapshot

Nanoparticles and prostate cancer

inferred← citeshttps://doi.org/10.1016/b978-0-12-819979-4.00005-2openalex-snapshot

Concept of smart nanospheres as nanocarriers

inferred← citeshttps://doi.org/10.1016/b978-0-12-820779-6.00004-9openalex-snapshot

Mesoporous silica nanoparticles for drug combination delivery in cancer therapy

inferred← citeshttps://doi.org/10.1016/b978-0-12-821250-9.00004-4openalex-snapshot

Ferroelectric properties and applications of dendrimer systems

inferred← citeshttps://doi.org/10.1016/b978-0-323-42863-7.00006-2openalex-snapshot

Nanotherapeutics promises for colorectal cancer and pancreatic ductal adenocarcinoma

inferred← citeshttps://doi.org/10.1016/b978-0-323-42863-7.00013-xopenalex-snapshot

Nanotechnology for cancer therapy

inferred← citeshttps://doi.org/10.1016/b978-0-323-46152-8.00006-8openalex-snapshot

Antimicrobial Nanostructures for Neurodegenerative Infections

inferred← citeshttps://doi.org/10.1016/b978-0-323-47347-7.00029-xopenalex-snapshot

Nanotherapeutic Platforms for Cancer Treatment: From Preclinical Development to Clinical Application

inferred← citeshttps://doi.org/10.1016/b978-0-323-52727-9.00007-8openalex-snapshot

Nanoparticles: A Novel Approach to Target Tumors

inferred← citeshttps://doi.org/10.1016/b978-0-323-85503-7.00010-9openalex-snapshot

Organic nanocarriers for targeted delivery of anticancer agents

inferred← citeshttps://doi.org/10.1016/b978-0-323-85873-1.00008-3openalex-snapshot

Nanotechnology-mediated combinational drug delivery approach for cancer therapy

inferred← citeshttps://doi.org/10.1016/b978-0-323-91376-8.00007-0openalex-snapshot

Bionanocomposites as a new platform for drug delivery systems

inferred← citeshttps://doi.org/10.1016/b978-0-443-14088-4.00002-2openalex-snapshot

Hybrid chitosan nanoparticles for sequential targeting of breast, liver, and brain cancer

inferred← citeshttps://doi.org/10.1016/b978-0-443-28836-4.00023-8openalex-snapshot

Nanotherapeutics in cancer-associated infections

inferred← citeshttps://doi.org/10.1016/b978-0-443-33641-6.01002-2openalex-snapshot

History, introduction, and physicochemical properties and characterization parameters of stimuli-responsive nanocarriers

inferred← citeshttps://doi.org/10.1016/b978-0-443-38307-6.00003-xopenalex-snapshot

Novel drug delivery systems for cancer therapy

inferred← citeshttps://doi.org/10.1016/b978-0-443-44185-1.00012-4openalex-snapshot

Materials and strategies for advanced anticancer drug delivery

inferred← citeshttps://doi.org/10.1016/j.actbio.2013.12.041openalex-snapshot

Sequentially releasing dual-drug-loaded PLGA–casein core/shell nanomedicine: Design, synthesis, biocompatibility and pharmacokinetics

inferred← citeshttps://doi.org/10.1016/j.actbio.2019.07.033openalex-snapshot

Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor

inferred← citeshttps://doi.org/10.1016/j.addr.2012.08.005openalex-snapshot

Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine

inferred← citeshttps://doi.org/10.1016/j.addr.2013.05.001openalex-snapshot

Cyclodextrin-based supramolecular systems for drug delivery: Recent progress and future perspective

inferred← citeshttps://doi.org/10.1016/j.addr.2013.09.016openalex-snapshot

Can nanomedicines kill cancer stem cells?

inferred← citeshttps://doi.org/10.1016/j.addr.2015.10.021openalex-snapshot

Co-delivery of chemotherapeutics and proteins for synergistic therapy

inferred← citeshttps://doi.org/10.1016/j.addr.2015.10.022openalex-snapshot

Recent advances of cocktail chemotherapy by combination drug delivery systems

inferred← citeshttps://doi.org/10.1016/j.addr.2017.04.003openalex-snapshot

Nanoformulation-based sequential combination cancer therapy

inferred← citeshttps://doi.org/10.1016/j.addr.2017.06.003openalex-snapshot

Nanoformulations for combination or cascade anticancer therapy

inferred← citeshttps://doi.org/10.1016/j.ajps.2018.12.002openalex-snapshot

Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency

inferred← citeshttps://doi.org/10.1016/j.bbcan.2014.05.002openalex-snapshot

Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2013.07.050openalex-snapshot

Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2013.12.018openalex-snapshot

Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2013.12.095openalex-snapshot

Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2014.02.006openalex-snapshot

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2014.04.034openalex-snapshot

Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2014.05.004openalex-snapshot

Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2014.07.043openalex-snapshot

Multi-layered nanoparticles for combination gene and drug delivery to tumors

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2014.10.018openalex-snapshot

Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2015.07.027openalex-snapshot

Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2015.08.048openalex-snapshot

Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells

inferred← citeshttps://doi.org/10.1016/j.biopha.2015.12.014openalex-snapshot

Nanoparticles: Novel vehicles in treatment of Glioblastoma

inferred← citeshttps://doi.org/10.1016/j.biopha.2015.12.025openalex-snapshot

Preparation and in vitro evaluation of 5-flourouracil loaded magnetite–zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications

inferred← citeshttps://doi.org/10.1016/j.biopha.2018.05.096openalex-snapshot

Co-encapsulation of dual drug loaded in MLNPs: Implication on sustained drug release and effectively inducing apoptosis in oral carcinoma cells

inferred← citeshttps://doi.org/10.1016/j.biopha.2018.11.122openalex-snapshot

Nanosoldiers: A promising strategy to combat triple negative breast cancer

inferred← citeshttps://doi.org/10.1016/j.biopha.2019.109561openalex-snapshot

Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC)

inferred← citeshttps://doi.org/10.1016/j.bios.2018.09.001openalex-snapshot

Improved microfluidic platform for simultaneous multiple drug screening towards personalized treatment

inferred← citeshttps://doi.org/10.1016/j.canlet.2017.12.023openalex-snapshot

Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo

inferred← citeshttps://doi.org/10.1016/j.carbpol.2015.01.064openalex-snapshot

Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin

inferred← citeshttps://doi.org/10.1016/j.carbpol.2015.04.036openalex-snapshot

Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel

inferred← citeshttps://doi.org/10.1016/j.carbpol.2016.08.072openalex-snapshot

Cisplatin-crosslinked glutathione-sensitive micelles loaded with doxorubicin for combination and targeted therapy of tumors

inferred← citeshttps://doi.org/10.1016/j.carbpol.2017.05.045openalex-snapshot

Nanoparticle assisted solvent selective transdermal combination therapy of curcumin and 5-flurouracil for efficient cancer treatment

inferred← citeshttps://doi.org/10.1016/j.carbpol.2022.119097openalex-snapshot

Co-delivery of doxorubicin and siRNA by all-trans retinoic acid conjugated chitosan-based nanocarriers for multiple synergistic antitumor efficacy

inferred← citeshttps://doi.org/10.1016/j.cbi.2021.109745openalex-snapshot

Promises of phytochemical based nano drug delivery systems in the management of cancer

inferred← citeshttps://doi.org/10.1016/j.ccr.2024.215796openalex-snapshot

Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy

inferred← citeshttps://doi.org/10.1016/j.cej.2020.125614openalex-snapshot

Programmable co-assembly of various drugs with temperature sensitive nanogels for optimizing combination chemotherapy

inferred← citeshttps://doi.org/10.1016/j.cej.2021.128947openalex-snapshot

Smart responsive nanoplatform via in situ forming disulfiram-copper ion chelation complex for cancer combination chemotherapy

inferred← citeshttps://doi.org/10.1016/j.colsurfb.2014.05.008openalex-snapshot

Preparation and characterization of ascorbic acid loaded solid lipid nanoparticles and investigation of their apoptotic effects

inferred← citeshttps://doi.org/10.1016/j.colsurfb.2016.03.054openalex-snapshot

Codelivery of doxorubicin-containing thermosensitive hydrogels incorporated with docetaxel-loaded mixed micelles enhances local cancer therapy

inferred← citeshttps://doi.org/10.1016/j.colsurfb.2017.09.017openalex-snapshot

Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin

inferred← citeshttps://doi.org/10.1016/j.colsurfb.2019.02.036openalex-snapshot

Poly (ethyl 2-cyanoacrylate) nanoparticles (PECA-NPs) as possible agents in tumor treatment

inferred← citeshttps://doi.org/10.1016/j.colsurfb.2020.111164openalex-snapshot

Floxuridine-chlorambucil conjugate nanodrugs for ovarian cancer combination chemotherapy

inferred← citeshttps://doi.org/10.1016/j.colsurfb.2020.111188openalex-snapshot

Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine

inferred← citeshttps://doi.org/10.1016/j.comptc.2020.112983openalex-snapshot

Investigation of host-guest interactions between polyester dendrimers and ibuprofen using density functional theory (DFT)

inferred← citeshttps://doi.org/10.1016/j.crphar.2022.100103openalex-snapshot

New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy

inferred← citeshttps://doi.org/10.1016/j.drudis.2012.05.010openalex-snapshot

Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy

inferred← citeshttps://doi.org/10.1016/j.ejpb.2015.03.003openalex-snapshot

Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice

inferred← citeshttps://doi.org/10.1016/j.ejpb.2015.03.018openalex-snapshot

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

inferred← citeshttps://doi.org/10.1016/j.ejpb.2015.04.017openalex-snapshot

Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment

inferred← citeshttps://doi.org/10.1016/j.ejpb.2017.10.005openalex-snapshot

Low level LED photodynamic therapy using curcumin loaded tetraether liposomes

inferred← citeshttps://doi.org/10.1016/j.ejpb.2019.09.017openalex-snapshot

A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine

inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.174131openalex-snapshot

Cytotoxicity and apoptosis of nanoparticles on osteosarcoma cells using doxorubicin and methotrexate: A systematic review

inferred← citeshttps://doi.org/10.1016/j.ejps.2016.08.021openalex-snapshot

Recent advances in drug delivery strategies for improved therapeutic efficacy of gemcitabine

inferred← citeshttps://doi.org/10.1016/j.ejps.2016.10.014openalex-snapshot

Development of biodegradable polyesters with various microstructures for highly controlled release of epirubicin and cyclophosphamide

inferred← citeshttps://doi.org/10.1016/j.ejps.2018.10.017openalex-snapshot

Combination drug therapy via nanocarriers against infectious diseases

inferred← citeshttps://doi.org/10.1016/j.ejps.2025.107043openalex-snapshot

Enhancement of the in vitro anti-leukemic effect of the histone deacetylase inhibitor romidepsin using Poly-(D, L-lactide-co-glycolide) nanoparticles as a drug carrier

inferred← citeshttps://doi.org/10.1016/j.enganabound.2022.12.020openalex-snapshot

Drug release using nanoparticles in the cancer cells on 2-D materials in order to target drug delivery: A numerical simulation via molecular dynamics method

inferred← citeshttps://doi.org/10.1016/j.eurpolymj.2018.11.038openalex-snapshot

DOX/ICG-carrying γ-PGA-g-PLGA-based polymeric nanoassemblies for acid-triggered rapid DOX release combined with NIR-activated photothermal effect

inferred← citeshttps://doi.org/10.1016/j.eurpolymj.2020.109546openalex-snapshot

Recent advances in dendrimer-based nanoplatform for cancer treatment: A review

inferred← citeshttps://doi.org/10.1016/j.eurpolymj.2021.110398openalex-snapshot

Synthesis of pH-sensitive nanocarriers based on polyacrylamide grafted nanocrystalline cellulose for targeted drug delivery to folate receptor in breast cancer cells

inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e20657openalex-snapshot

Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer Activities

inferred← citeshttps://doi.org/10.1016/j.hybadv.2024.100210openalex-snapshot

Novel pH-responsive hybrid hydrogels for controlled delivery of curcumin: Overcoming conventional constraints and enhancing cytotoxicity in MCF-7 cells

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2019.05.217openalex-snapshot

Chitosan capped ZnO nanoparticles with cell specific apoptosis induction through P53 activation and G2/M arrest in breast cancer cells – In vitro approaches

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2021.01.067openalex-snapshot

Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe2O3 nanocomposite for drug delivery application: Emphasis on ameliorating restrictions

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.11.226openalex-snapshot

Synthesis and characterization of a novel, pH-responsive sustained release nanocarrier using polyethylene glycol, graphene oxide, and natural silk fibroin protein by a green nano emulsification method to enhance cancer treatment

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.128736openalex-snapshot

A green approach for preparation of chitosan/hydroxyapatite/graphitic carbon nitride hydrogel nanocomposite for improved 5-FU delivery

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.135022openalex-snapshot

Overcoming resistance: Chitosan-modified liposomes as targeted drug carriers in the fight against multidrug resistant bacteria-a review

inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.147469openalex-snapshot

Preparation and evaluation of anti-hepatocellular carcinoma activity of oridonin nanoparticles using Angelica sinensis polysaccharide and ursodeoxycholic acid as carrier

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2014.09.055openalex-snapshot

Construction of a two-in-one liposomal system (TWOLips) for tumor-targeted combination therapy

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2016.09.063openalex-snapshot

Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2017.09.060openalex-snapshot

Co-delivery strategies to overcome multidrug resistance in ovarian cancer

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2019.02.009openalex-snapshot

Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2022.121942openalex-snapshot

Co–encapsulation of flavonoids with anti–cancer drugs: A challenge ahead

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.122905openalex-snapshot

In depth characterization of physicochemical critical quality attributes of a clinical drug-dendrimer conjugate

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.123976openalex-snapshot

Multifunctionality of cyclodextrin-based polymeric nanoparticulate delivery systems for chemotherapeutics, combination therapy, and theranostics

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.124897openalex-snapshot

Codelivery of metformin and methotrexate with optimized chitosan nanoparticles for synergistic triple-negative breast cancer therapy in vivo

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2026.127499openalex-snapshot

Redox-responsive and liver-targeted nanoplatform for paclitaxel delivery toward hepatocellular carcinoma therapy

inferred← citeshttps://doi.org/10.1016/j.jafr.2021.100107openalex-snapshot

Co-delivery of synergistic antioxidants from food sources for the prevention of oxidative stress

inferred← citeshttps://doi.org/10.1016/j.jconrel.2012.11.009openalex-snapshot

Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester

inferred← citeshttps://doi.org/10.1016/j.jconrel.2013.05.011openalex-snapshot

Formation of artificial multicompartment vesosome and dendrosome as prospected drug and gene delivery carriers

inferred← citeshttps://doi.org/10.1016/j.jconrel.2013.05.036openalex-snapshot

Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles

inferred← citeshttps://doi.org/10.1016/j.jconrel.2013.08.022openalex-snapshot

Spatial–temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy

inferred← citeshttps://doi.org/10.1016/j.jconrel.2014.05.002openalex-snapshot

Stimuli-sensitive nanopreparations for combination cancer therapy

inferred← citeshttps://doi.org/10.1016/j.jconrel.2015.06.034openalex-snapshot

Supramolecular nanoscale assemblies for cancer diagnosis and therapy

inferred← citeshttps://doi.org/10.1016/j.jconrel.2015.12.015openalex-snapshot

PEG- b -PLA micelles and PLGA- b -PEG- b -PLGA sol–gels for drug delivery

inferred← citeshttps://doi.org/10.1016/j.jconrel.2017.05.028openalex-snapshot

PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application

inferred← citeshttps://doi.org/10.1016/j.jconrel.2018.12.013openalex-snapshot

Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy

inferred← citeshttps://doi.org/10.1016/j.jconrel.2019.01.009openalex-snapshot

New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment

inferred← citeshttps://doi.org/10.1016/j.jconrel.2019.04.020openalex-snapshot

Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments

showing the first 200 of 556 · page through all 556

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.